Ensysce Biosciences raises over $21 million in Series C preferred stock private placement - ENSC News | RalliesEnsysce Biosciences raises over $21 million in Series C preferred stock private placement
E
ENSC• Private placement financing details
- Ensysce Biosciences entered a private financing to sell 120,260 shares of Series C Preferred Stock for about $43 million in two tranches.
- Initial tranche closed Aug. 7, raising more than $21 million in gross proceeds.
- Second tranche remains pending, subject to a clinical trial milestone.
